Search

Your search keyword '"Moran, B. J."' showing total 469 results
Start Over Author "Moran, B. J."
469 results on '"Moran, B. J."'

2. A defunctioning stoma significantly prolongs the length of stay in laparoscopic colorectal resection

Author

Cartmell, Mark, Jones, Oliver, Moran, B. J., and Cecil, T. D.

Abstract

Abstract: Background: Reduction in length of stay has several advantages, including healthcare costs, patient choice, and minimizing hospital acquired infections. Additionally, length of stay is a surrogate marker of rate of recovery from the physiological insult of anaesthesia and surgery and complications thereof. A well-documented short-term benefit of laparoscopic compared to open colorectal resection is reduced length of stay. Methods: This was a review of prospectively collected data on all laparoscopic colorectal resections performed in our unit. We analyzed patients having primary colorectal anastomosis, to assess the effect of conversion compared to completion laparoscopically. Furthermore we compared those with or without diverting stoma, for the effect of stoma formation on postoperative length of stay (LOS). Results: Two hundred and thirteen patients had a colorectal resection. Of these 133 (62%) were left-sided or rectal resections. Resection with primary colorectal anastomosis was undertaken in 112 patients. A defunctioning stoma was performed in 13/112 (12%), and 32/112 (29%) were converted as the procedure could not be completed laparoscopically. Conversion was not significantly associated with increased LOS with weighted median of 6.5 and 6 days for conversion and no conversion, respectively. However, stoma formation significantly increased LOS to a median of 10 days compared with a median of 6 days in patients without a stoma (p = 0.001, Mann–Whitney U). Conclusions: The need for conversion, if performed in a timely and appropriate manner, has little impact on patient outcome compared to those completed laparoscopically, with no significant increase in LOS in our experience. In contrast, a diverting stoma does prolong LOS and some of the benefits of laparoscopic surgery may be lost unless patients requiring a stoma are identified preoperatively and have intensive pre- and postoperative stoma training.

Published
2024
Full Text
View/download PDF

7. Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei: Estudio multicéntrico de la curva de aprendizaje y la realización del procedimiento quirúrgico en la cirugía citorreductora con quimioterapia intraperitoneal para el pseudomixoma peritoneal

Author

Kusamura, S., Moran, B. J., Sugarbaker, P. H., Levine, E. A., Elias, D., Baratti, D., Morris, D. L., Sardi, A., Glehen, O., and Deraco, M.

Published
2014

12. Appendiceal Tumours and Pseudomyxoma Peritonei: Literature Review with PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis and Treatment

Author

Govaerts, K, Lurvink, R J, de Hingh, I H J T, Van der Speeten, K, Villeneuve, L, Kusamura, S, Kepenekian, V, Deraco, M, Glehen, O, Moran, B J, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M, Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W, Mohamed, Faheez, Morris, David L, Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A, et al, University of Zurich, and Govaerts, K

Subjects
Oncology, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021

13. The delphi and GRADE methodology used in the PSOGI 2018 consensus statement on pseudomyxoma peritonei and peritoneal mesothelioma

Author

Lurvink, R J, Villeneuve, L, Govaerts, K, de Hingh, I H J T, Moran, B J, Deraco, M, Van der Speeten, K, Glehen, O, Kepenekian, V, Kusamura, S, Alyami, Mohammad S, André, Thierry, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Bhatt, Aditi, Ben-Yaacov, Almog, Bertulli, Rosella, Braess, Jan, Burger, Jacobus W A, Cascales-Campos, Pedro, Cashin, Peter, Cecil, P, Tom, Ceelen, Wim P, Creemers, Geert-Jan, Cortes-Guiral, Delia, Dayal, Sanjeev, De Simone, Michele, Di Bartolomeo, Maria, Dube, Pierre, Flatmark, Kjersti, et al, University of Zurich, and Kusamura, S

Subjects
Delphi consensus, GRADE system, Oncology, Peritoneal mesothelioma, Peritoneal surface malignancies, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, Pseudomyxoma peritonei, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021

14. Peritoneal Mesothelioma: PSOGI/EURACAN Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up

Author

Kusamura, S, Kepenekian, V, Villeneuve, L, Lurvink, R J, Govaerts, K, De Hingh, I H J T, Moran, B J, Van der Speeten, K, Deraco, M, Glehen, O, Barrios-Sanchez, Pedro, Baumgartner, Joel M, Ben-Yaacov, Almog, Bertulli, Rosella, Cashin, Peter, Cecil, Tom, Dayal, Sanjeev, De Simone, Michele, Foster, Jason M, Goere, Diane, Lehmann, Kuno, Li, Yan, Loggie, Brian W, Mohamed, Faheez, Morris, David L, Nissan, Aviram, Piso, Pompiliu, Pocard, Marc, Rau, Beate, Reymond, Marc A, et al, University of Zurich, and Deraco, M

Subjects
Oncology, 610 Medicine & health, 2730 Oncology, Surgery, General Medicine, 10217 Clinic for Visceral and Transplantation Surgery, 2746 Surgery
Published
2021
Full Text
View/download PDF

17. Biological mesh is a safe and effective method of abdominal wall reconstruction in cytoreductive surgery for peritoneal malignancy

Author

Tzivanakis, A., Dayal, S. P., Arnold, S. J., Mohamed, F., Cecil, T. D., Venkatasubramaniam, A. K., and Moran, B. J.

Subjects
Original Article, Original Articles
Abstract

Background Patients with peritoneal malignancy often have multiple laparotomies before referral for cytoreductive surgery (CRS). Some have substantial abdominal wall herniation and tumour infiltration of abdominal incisions. CRS involves complete macroscopic tumour removal and hyperthermic intraperitoneal chemotherapy (HIPEC). Abdominal wall reconstruction is problematic in these patients. The aim of this study was to establish immediate and long‐term outcomes of abdominal wall reconstruction with biological mesh in a single centre. Methods A dedicated peritoneal malignancy database was searched for all patients who had biological mesh abdominal wall reconstruction between 2004 and 2015. Short‐ and long‐term outcomes were reviewed. All patients had annual abdominal CT as routine peritoneal malignancy follow‐up. Results Some 33 patients (22 women) with a mean age of 53·4 (range 19–82) years underwent abdominal wall reconstruction with biological mesh. The majority (23) had CRS for pseudomyxoma (19 low grade), six for colorectal peritoneal metastasis and four for appendiceal adenocarcinoma; 18 had undergone CRS and HIPEC previously. Twenty‐five of the 33 patients had abdominal wall tumour involvement and eight had concurrent hernias. The mean duration of surgery was 486 (range 120–795) min and the mean mesh size used was 345 (50–654) cm2. Ten patients developed wound infections and four had a seroma. Two developed early enterocutaneous fistulas. Mean follow‐up was 48 months. Five patients developed an incisional hernia. Four died from progressive malignancy. A further 15 patients had disease recurrence, but only one had isolated abdominal wall recurrence. Conclusion Biological mesh was safe and effective for abdominal wall reconstruction in peritoneal malignancy. Postoperative wound infections were frequent but nevertheless incisional hernia rates were low with no instances of mesh‐related bowel erosion or fistulation.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results